A Comprehensive Review of Outcome Predictors in Low MELD Patients
- 1 February 2020
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 104 (2), 242-250
- https://doi.org/10.1097/tp.0000000000002956
Abstract
Risk scoring for patients with cirrhosis has evolved greatly over the past several decades. However, patients with low Model for End-Stage Liver Disease–Sodium scores still suffer from liver-related morbidity and mortality. Unfortunately, it is not clear which of these low Model for End-Stage Liver Disease–Sodium score patients would benefit from earlier consideration of liver transplantation. This article reviews the literature of risk prediction in patients with cirrhosis, identifies which patients may benefit from earlier interventions, such as transplantation, and proposes directions for future research.This publication has 95 references indexed in Scilit:
- Revision of MELD to Include Serum Albumin Improves Prediction of Mortality on the Liver Transplant Waiting ListPLOS ONE, 2013
- Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stentEuropean Journal of Gastroenterology & Hepatology, 2013
- Muscle Wasting Is Associated With Mortality in Patients With CirrhosisClinical Gastroenterology and Hepatology, 2012
- Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis trialJournal of Hepatology, 2011
- Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation eraJournal of Hepatology, 2011
- Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality riskLiver Transplantation, 2010
- Survival Benefit-Based Deceased-Donor Liver AllocationAmerican Journal of Transplantation, 2009
- Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver diseaseGut, 2007
- Evaluation of the increase in model for end-stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child–Turcotte–Pugh scoreJournal of Hepatology, 2005
- A model to predict survival in patients with end-stage liver diseaseJournal of Hepatology, 2001